These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 9816323

  • 1. Biochemical modulation in the treatment of advanced cancer: a study of combined leucovorin, fluorouracil, and iododeoxyuridine.
    Marshall JL, Richmond E, DeLap RJ.
    Clin Cancer Res; 1996 Sep; 2(9):1475-80. PubMed ID: 9816323
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
    Yoshino T, Boku N, Onozawa Y, Hironaka S, Fukutomi A, Yamaguchi Y, Hasuike N, Yamazaki K, Machida N, Ono H.
    Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
    [Abstract] [Full Text] [Related]

  • 3. The Spanish experience with high-dose infusional 5-fluorouracil (5-FU) in colorectal cancer. The Spanish Cooperative Group For Gastrointestinal Tumor Therapy (TTD).
    Aranda E, Cervantes A, Carrato A, Antón-Torres A, Massutí T, Fernández-Martos C, Díaz-Rubio E.
    J Infus Chemother; 1996 Sep; 6(3):118-22. PubMed ID: 9229321
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.
    Kemeny N, Garay CA, Gurtler J, Hochster H, Kennedy P, Benson A, Brandt DS, Polikoff J, Wertheim M, Shumaker G, Hallman D, Burger B, Gupta S.
    J Clin Oncol; 2004 Dec 01; 22(23):4753-61. PubMed ID: 15570076
    [Abstract] [Full Text] [Related]

  • 10. Imatinib mesylate for targeting the platelet-derived growth factor beta receptor in combination with fluorouracil and leucovorin in patients with refractory pancreatic, bile duct, colorectal, or gastric cancer--a dose-escalation Phase I trial.
    Al-Batran SE, Atmaca A, Schleyer E, Pauligk C, Hosius C, Ehninger G, Jäger E.
    Cancer; 2007 May 01; 109(9):1897-904. PubMed ID: 17377918
    [Abstract] [Full Text] [Related]

  • 11. Double modulation of 5-fluorouracil by leucovorin and low-dose methotrexate in advanced colorectal cancer.
    Stabuc B, Markovic A, Plesnicar A, Cizej TE.
    Neoplasma; 2000 May 01; 47(4):248-52. PubMed ID: 11043831
    [Abstract] [Full Text] [Related]

  • 12. A phase II trial of modified FOLFOX as first-line chemotherapy in advanced colorectal cancer.
    Xiong JP, Zhang L, Zhong LX, Qiu F, Xu J, Tao QS, Xiang XJ, Yu F, Tang XM.
    Anticancer Drugs; 2007 Oct 01; 18(9):1103-7. PubMed ID: 17704661
    [Abstract] [Full Text] [Related]

  • 13. [10-hydroxy-camptothecin plus fluorouracil/leucovorin for the treatment of patients with advanced colorectal cancer].
    Zhang HG, Cai RG, Chen SS, Wu F, Chu DT.
    Zhonghua Yi Xue Za Zhi; 2007 Jun 05; 87(21):1462-4. PubMed ID: 17785082
    [Abstract] [Full Text] [Related]

  • 14. Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer.
    Caponigro F, Avallone A, McLeod H, Cartenì G, De Vita F, Casaretti R, Morsman J, Blackie R, Budillon A, De Lucia L, Gravina A, Catalano G, Comella P, Comella G.
    Clin Cancer Res; 1999 Dec 05; 5(12):3948-55. PubMed ID: 10632324
    [Abstract] [Full Text] [Related]

  • 15. Phase II study of weekly oxaliplatin and high-dose infusional 5-fluorouracil plus leucovorin in pretreated patients with metastatic colorectal cancer.
    Chiara S, Nobile MT, Gozza A, Taveggia P, Heouaine A, Pastrone I, Percivale PL, Lionetto R, Sanguineti O, Rosso R.
    Anticancer Res; 2004 Dec 05; 24(1):355-60. PubMed ID: 15015621
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A phase I trial of a modified, dose intensive FAMTX regimen (high dose 5-fluorouracil+doxorubicin+high dose methotrexate+leucovorin) with oral uridine rescue.
    Schwartz GK, Christman K, Saltz L, Casper E, Quan V, Bertino J, Martin DS, Colofiore J, Kelsen D.
    Cancer; 1996 Nov 01; 78(9):1988-95. PubMed ID: 8909321
    [Abstract] [Full Text] [Related]

  • 20. A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancer.
    Oh SY, Kwon HC, Seo BG, Kim SH, Kim JS, Kim HJ.
    Acta Oncol; 2007 Nov 01; 46(3):336-41. PubMed ID: 17450469
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.